Stockhead on MSN
LTR Pharma doses first patients in SPONTAN Phase II study for ED
The first patients have been dosed in LTR Pharma’s Phase II pharmacokinetic clinical study of SPONTAN, its nasal spray to ...
Although ED is common, you don’t have to live with it. Our urological specialists understand your hesitation and frustration. We offer a range of personalized treatments to help you achieve the sexual ...
Steffini Stalos, DO, FCAP, is a pathology and lab medicine physician. She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Erectile dysfunction (ED) makes you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results